TLX – telix pharmaceuticals limited - american depositary shares (US:NASDAQ)
Stock Stats
News
First Patient Dosed in Pivotal Phase 3 Study of TLX591-Px (Illuccix®) for Prostate Cancer Imaging in Japanese Patients
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Telix Pharmaceuticals (NASDAQ:TLX) was upgraded by analysts at Wall Stree
Telix Pharmaceuticals (NASDAQ:TLX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch
Form 6-K Telix Pharmaceuticals For: Jan 19
Form 6-K Telix Pharmaceuticals For: Jan 12
Form 6-K Telix Pharmaceuticals For: Dec 21
Form 6-K Telix Pharmaceuticals For: Dec 17
Form 6-K Telix Pharmaceuticals For: Dec 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.